Study to Evaluate the Safety and Effects AZD0530 on Prostate and Breast Cancer Subjects With Metastatic Bone Disease
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Prostate Cancer|Bone Neoplasms
Interventions: DRUG: AZD0530|DRUG: Zoledronic Acid
Sponsor: AstraZeneca